Showing results (11-20 of 109) with videos related to

Sort By:
Pageof 11
BMC Rheumatology|August 9, 2020
Immune checkpoint inhibitor-induced inflammatory arthritis: a qualitative study identifying unmet patient needs and care gapsLaura C Cappelli, Suzanne M Grieb, Ami A Shah, et al.
Dermatology and Therapy|September 15, 2023
Efficacy of Guselkumab in Treating Nails, Scalp, Hands, and Feet in Patients with Psoriasis and Self-reported Psoriatic ArthritisAna-Maria Orbai, Soumya D Chakravarty, Yin You, et al.
The Journal of Rheumatology|March 3, 2015
More than Just Minutes of Stiffness in the Morning: Report from the OMERACT Rheumatoid Arthritis Flare Group Stiffness Breakout SessionsAna-Maria Orbai, Serena Halls, Sarah Hewlett, et al.
Medicine|June 27, 2012
A novel dermato-pulmonary syndrome associated with MDA-5 antibodies: report of 2 cases and review of the literatureNeal F Chaisson, Julie Paik, Ana-Maria Orbai, et al.
The Journal of Rheumatology|August 21, 2025
Composite Outcome Measures for Psoriatic Arthritis: Project Updates 2024Andre L Ribeiro, Tommy Kok Annfeldt, Dafna D Gladman, et al.
The Journal of Rheumatology|August 5, 2025
Composite Outcome Measures for Psoriatic Arthritis: Project Updates 2024Andre L Ribeiro, Tommy Kok Annfeldt, Dafna D Gladman, et al.
RMD Open|September 21, 2018
Ixekizumab is efficacious when used alone or when added to conventional synthetic disease-modifying antirheumatic drugs (cDMARDs) in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor inhibitorsPeter Nash, Frank Behrens, Ana-Maria Orbai, et al.
RMD Open|January 21, 2020
Fatigue numeric rating scale validity, discrimination and responder definition in patients with psoriatic arthritisDafna Gladman, Peter Nash, Hitoshi Goto, et al.
Plos One|September 18, 2015
Reliability and Validity of Selected PROMIS Measures in People with Rheumatoid ArthritisSusan J Bartlett, Ana-Maria Orbai, Trisha Duncan, et al.
BMC Rheumatology|August 31, 2022
Effect of tofacitinib on dactylitis and patient-reported outcomes in patients with active psoriatic arthritis: post-hoc analysis of phase III studiesAna-Maria Orbai, Philip J Mease, Philip S Helliwell, et al.
Pageof 11